Cover Page
Cover Page | Jun. 28, 2021 | Apr. 26, 2021 |
Cover [Abstract] | ||
Document Type | 8-K | |
Document Period End Date | Jun. 28, 2021 | |
Entity Registrant Name | Esperion Therapeutics, Inc. | |
Entity Incorporation, State or Country Code | DE | |
Entity File Number | 001-35986 | |
Entity Tax Identification Number | 26-1870780 | |
Entity Address, Address Line One | 3891 Ranchero Drive | |
Entity Address, Address Line Two | Suite 150 | |
Entity Address, City or Town | Ann Arbor | |
Entity Address, State or Province | MI | |
Entity Address, Postal Zip Code | 48108 | |
City Area Code | 734 | |
Local Phone Number | 887-3903 | |
Written Communications | false | |
Soliciting Material | false | |
Pre-commencement Tender Offer | false | |
Pre-commencement Issuer Tender Offer | false | |
Title of 12(b) Security | Common Stock, par value $0.001 per share | |
Trading Symbol | ESPR | |
Security Exchange Name | NASDAQ | |
Entity Emerging Growth Company | false | |
Amendment Flag | false | |
Entity Central Index Key | 0001434868 |